Objectives: Hfq is a bacterial RNA chaperone involved in the post-transcriptional regulation of many stressinducible genes via small non-coding RNAs. Although Hfq is related to important phenotypes including virulence in many bacterial pathogens, its role in drug resistance is unknown. The aim of this study was to investigate the role of Hfq in bacterial multidrug resistance.
Introduction
Multidrug efflux pumps cause serious problems in cancer chemotherapy and the treatment of bacterial infections. Bacterial drug resistance is often associated with multidrug efflux pumps, which can decrease drug accumulation within the cell. 1 Bacterial multidrug efflux pumps are classified into five families on the basis of sequence similarity as: major facilitator; resistance -nodulation -cell division (RND); small multidrug resistance; multidrug and toxic compound extrusion; and ATPbinding cassette. 2 Of these, the RND family of efflux pumps plays major roles in both intrinsic and elevated resistance of Gram-negative bacteria to a wide range of compounds. 1 RND efflux pumps require two other proteins to function, namely a membrane fusion protein and an outer membrane protein.
The AcrAB efflux system, present in most Enterobacteriaceae, belongs to the RND family of efflux pumps and utilizes the outer membrane protein TolC. 1 There are many putative and proven drug efflux pumps in the Escherichia coli genome. 3 Since many such efflux pumps have overlapping substrate spectra, it is intriguing that bacteria, with their economically organized genomes, harbour such large sets of multidrug efflux genes.
The key to understanding how bacteria utilize these multiple efflux pumps lies in the regulation of pump expression. The currently available data show that multidrug efflux pumps are often expressed under precise and elaborate transcriptional control. 2 Expression of acrAB, which encodes the major AcrAB efflux pump, is subject to multiple levels of regulation. It is modulated locally by the repressors AcrR and AcrS 4, 5 and on a wider level by stress conditions and global regulators such as MarA, SoxS and Rob. 2 These examples illustrate the complexity and diversity of the mechanisms regulating bacterial multidrug efflux pumps.
Hfq is a well-conserved RNA-binding protein that was originally identified in E. coli as a host factor required for the replication of Qb bacteriophage. 6 It functions in a hexameric ring-shaped structure as an RNA chaperone 7 by mediating the binding of small RNAs (sRNAs) preferentially to single-stranded AU-rich regions of mRNA targets. 8 sRNAs often bind to the 5 ′ -untranslated leader region of cognate messengers to modulate their stability and/or translation. 9, 10 Since many transcriptional regulators are subject to post-transcriptional regulation mediated by sRNAs in conjunction with Hfq, an hfq mutant shows pleiotropic phenotypes. 11 In recent years, Hfq has been established as an important virulence factor in bacterial pathogens. 12 Although there is much evidence that Hfq is related to bacterial virulence, the role of Hfq in bacterial multidrug resistance is yet to be defined. Here, we demonstrate that Hfq affects drug susceptibilities and accumulation in E. coli. In addition, we show that the AcrAB drug efflux system contributes to the Hfq-mediated drug resistance and that Hfq regulates the production of AcrB at the post-transcriptional level. Our data suggest that Hfq plays an important role in controlling the AcrB level and thereby mediates drug resistance in E. coli.
Materials and methods

Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed in Table 1 . E. coli strains were derived from the wild-type strains W3104 3 and MC4100. 13 Bacterial strains were grown at 378C in Luria-Bertani (LB) broth. 14 
Construction of gene deletion mutants
To construct the hfq and acrAB deletion mutant from E. coli W3104 and MC4100 cells, the precise in-frame deletions were generated by crossover PCR. The following oligonucleotide primers were used: hfq-No (CGCGG ATCCTAAAACTTTAACGGAACTGAC); hfq-Ni (CACGCAATAACCTTCACACTCCAA ATTTATAACCATTCTCTCTTTTCCTTATATGCTTAT); hfq-Co (CGCGTCGACTGGGTC CAGCCACGCACCAGG); hfq-Ci (GTTATAAATTTGGAGTGTGAAGGTTATTGCGTGT AAGGTTTCGGGCTGTTTTTTTACACG); acrA-No (CGCGGATCCATTCGCATTTGTG GAATATAATCTCCATCA); acrA-Ni (CACGCAATAACCTTCACACTCCAAATTTATA ACCATATGTAAACCTCGAGTGTCCG), acrB-Co (CGCGGATCCATGGAAAAAAC TTACTGACCTGGAC); and acrB-Ci (GTTATAAATTTGGAGTGTGAAGGTTATTGC GTGTGATACAACGTGTAATCACTAAGGCC). The fragment containing the deletion was then cloned into the BamHI-SalI (for hfq deletion) or BamHI sites (for acrAB deletion) (underlined in the primer sequences above) of the pKO3 vector, 15 which is a gene replacement vector that contains a temperature-sensitive origin of replication and markers for positive and negative selection for chromosomal integration and excision. The deletion was introduced into the chromosome by use of the pKO3 gene replacement protocol, as described previously. 15 The plasmid obtained was electroporated into W3104 and MC4100. Cells were then recovered in 1 mL of SOC (2% Bacto tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl 2 , 20 mM glucose) for 1 h at 308C. Cells were plated on chloramphenicol (20 mg/L) -containing LB agar plates and incubated at 438C overnight. From these plates, five colonies were picked up and inoculated into 1 mL of LB. Cells were then plated at 308C on 5% (w/v) sucrose plates. The outgrowing bacteria were plated on LB plates with or without chloramphenicol at 308C. Chloramphenicolsusceptible mutants were selected. Chromosomal insertions and deletions were confirmed by PCR. Yamada et al.
Plasmid construction
The hfq gene was amplified from W3104 genomic DNA using primers CGCGTTAACATGTGTACAATTGAGACGTAT and CGCCTGCAGGCGTATAACCCTC TAAATAGA, which introduced HincII and PstI sites (underlined in the primer sequences above). The PCR fragment contained a region from 85 bp upstream to 75 bp downstream of the hfq gene. The fragment was cleaved with HincII and PstI, and then cloned into the corresponding sites of pACYC177, resulting in phfq (Table 1) . To produce pacrAB, the acrAB genes were amplified by using primers CGCGGATCCATGTTCGT GAATTTACAGGCG and CGCGCATGCAACGCGTCCCCTTCTTAGC, which introduced BamHI and SphI sites (underlined in the primer sequences above). This fragment contained a region from 140 bp upstream of acrA to 545 bp downstream of acrB. The fragment was cleaved with BamHI and SphI, and then cloned into the corresponding sites of pHSG398, resulting in pacrAB ( Table 1) .
Determination of MICs of toxic compounds
The antibacterial activities of various agents were determined on LB agar (1% tryptone, 0.5% yeast extract, 0.5% NaCl) plates containing chloramphenicol, novobiocin, acriflavine, Crystal Violet, rhodamine 6G, benzalkonium, oxacillin, cefamandole or nalidixic acid (Sigma, St Louis, MO, USA) at various concentrations. Agar plates were made by the 2-fold agar dilution technique, as described previously. 16 -18 To determine the MICs, bacteria were grown in LB broth at 378C overnight, diluted into the same medium and then tested at a final inoculum size of 10 5 cfu/mL using a multipoint inoculator (Sakuma Seisakusyo, Tokyo, Japan) after incubation at 378C for 20 h. The MIC was the lowest concentration of compound that inhibited cell growth.
Observation of drug accumulation in E. coli cells E. coli cells were spotted onto LB agar plates containing rhodamine 6G (0.5 or 1 mg/L) at a final inoculum size of 10 5 cfu/spot, using a multipoint inoculator (Sakuma Seisakusyo), and were incubated at 378C for 20 h. Drug accumulation in E. coli cells was observed as the staining of cells with rhodamine 6G by using a scanner (K100D super; Pentax, Tokyo, Japan).
Reporter gene assay
To investigate the transcription of acrAB and tolC, the promoter regions of these genes were cloned in front of the lacZ reporter gene in a single-copy pNN387 vector. 19 The resulting plasmids were transformed into the MC4100 strain for b-galactosidase activity measurements. Then, transformants were grown at 378C in LB broth containing 15 mg/L chloramphenicol until the optical density at 600 nm reached 0.6. b-Galactosidase activity in cell lysates was assayed using o-nitrophenyl-b-D-galactopyranoside as a substrate, as described by Miller, 20 with a slight modification.
Detection of AcrB
AcrB production was determined as follows. E. coli cells were grown in LB broth until the optical density at 600 nm reached 0.6. The cells were harvested, washed twice with 50 mM potassium phosphate buffer (pH 7.0) and then disrupted by sonication with a Branson Sonifier 250D (Branson Ultrasonics Corp., CT, USA) for 1.5 min. After undisrupted cells were removed by low-speed centrifugation (10 000 g, 10 min), the membrane fraction was collected by ultracentrifugation (200000 g, 30 min). The membrane fraction was then resuspended in 50 mM potassium phosphate buffer (pH 7.0). Cell membrane fractions were standardized to 15 mg of protein and were then separated by SDS-PAGE on an 8% polyacrylamide gel, followed by electroblotting onto a polyvinylidene difluoride membrane. The AcrB protein was detected with polyclonal anti-AcrB antibodies, 4 alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G (Bio-Rad Laboratories, CA, USA) and the CDP-Star reagent (GE Healthcare, Tokyo, Japan), as described previously. 4 Production of AcrB was scanned using LAS-3000 (Fujifilm, Tokyo, Japan) and quantified by Science Lab 2001 Image Gauge Ver. 4.0 software (Fujifilm, Tokyo, Japan).
Results
Effect of Hfq on drug susceptibilities of E. coli
To investigate the role of Hfq in drug susceptibilities, the hfq gene was deleted from E. coli strains W3104 and MC4100, as described in the Materials and methods section. In both backgrounds, hfq mutants were susceptible to chloramphenicol (4-fold), novobiocin (4-fold), acriflavine (8-fold), Crystal Violet (4-fold), rhodamine 6G (.4-fold), benzalkonium (8-fold), oxacillin (4-fold), cefamandole (4-fold) and nalidixic acid (4-fold), compared with the parental strains ( Table 2 ). In both W3104 and MC4100, Dhfq strains complemented with phfq behaved like the wild-type. These data indicate that Hfq affects the intrinsic multidrug resistance of E. coli.
Hfq affects drug accumulation in E. coli
One of the major mechanisms of bacterial multidrug resistance is active drug efflux. Enhanced drug efflux activity reduces intracellular drug accumulation. 21 Therefore, we investigated the effect of Hfq on drug accumulation in E. coli cells. E. coli W3104, W3104Dhfq and W3104DacrAB cells were spotted onto agar plates containing 0.5 or 1 mg/L of rhodamine 6G and the plates were then incubated at 378C for 20 h. Rhodamine 6G did not inhibit cell growth at these concentrations ( Figure 1) ; however, a difference in the colour of cells was observed between these strains. The W3104Dhfq and W3104DacrAB strains appeared red on plates containing rhodamine 6G, whereas the W3104 strain was white. This result indicates greater drug accumulation in the W3104Dhfq and W3104DacrAB strains, suggesting decreased drug efflux activities in these strains compared with the wild-type strain (Figure 1 ). An identical difference in rhodamine 6G accumulation between MC4100 and MC4100Dhfq was also observed (data not shown).
AcrAB drug efflux system contributes to Hfq-mediated drug susceptibility
The results described above indicate that the drug efflux activity of E. coli may be impaired by hfq deletion. In a previous study, we revealed that at least 20 intrinsic drug efflux systems are encoded in the E. coli chromosome. 3 Among these, the AcrAB efflux system plays major roles in both intrinsic and elevated resistance of E. coli to a wide range of noxious compounds. 1 In order to determine whether the AcrAB multidrug efflux system contributes to the Hfq-regulated drug resistance level of E. coli, we investigated the effect of hfq deletion on the drug susceptibilities of the acrAB deletion mutant ( Table 2 ). The hfq deletion did not affect the drug susceptibilities of W3104DacrAB or MC4100DacrAB against chloramphenicol, acriflavine, Crystal Violet, rhodamine 6G, benzalkonium, oxacillin, cefamandole or Role of Hfq in drug resistance 855 JAC nalidixic acid, whereas it results in increased drug susceptibilities in W3104 and MC4100 (Table 2) . When the DacrABDhfq strains were transformed with pacrAB and phfq, the transformants behaved like the wild-type (Table 2 ). These results indicate that the AcrAB efflux system contributes to the Hfq-controlled drug resistance in E. coli.
Promoter activities of drug efflux systems
The results above suggest the possibility that the AcrAB efflux system is regulated by Hfq. To determine whether Hfq affects AcrAB expression at the transcriptional level, the promoter region of the acrAB operon was cloned in front of the lacZ reporter gene in a single-copy pNN387 vector, and the promoter activity was determined as b-galactosidase activity. The promoter activity of the tolC outer membrane channel was also measured. As shown in Figure 2 , there are no significant changes in the promoter activities of acrAB and tolC in MC4100Dhfq compared with those in MC4100. Thus, Hfq does not affect acrAB and tolC transcription.
Hfq regulates the production level of the AcrB drug efflux system
To test whether Hfq affects AcrB production, we examined the production level of the AcrB protein in MC4100 and MC4100Dhfq using western blot analysis. As shown in Figure 3(a) , the production level of AcrB in MC4100Dhfq was lower than that in MC4100. Quantification with Image Gauge software (Fujifilm, Tokyo, Japan) identified that the production of AcrB in the hfq mutant is 53% compared with that in the MC4100 strain (Figure 3b ). These data indicate that Hfq affects AcrB expression at the post-transcriptional level. Figure 1 . Hfq affects drug accumulation in E. coli. Strains W3104 (wild-type), NKE461 (W3104Dhfq) and NKE19 (W3104DacrAB) were spotted onto LB agar plates containing 0.5 or 1 mg/L rhodamine 6G. After incubation at 378C for 20 h, E. coli colonies were observed under visible white light. Yamada et al.
Discussion
To survive in natural environments it is important for bacteria to coordinate gene expression in response to environmental stimuli. Consequently, several genes are often controlled by complex regulatory networks that integrate environmental signals. As described above, the AcrAB-TolC efflux system is effective in generating drug resistance and has wide substrate specificity, and the expression of acrAB is subjected to multiple levels of regulation. It is regulated by AcrR, MarA, SoxS and Rob. 2 Recently, we found that acrAB is also regulated by AcrS, which was believed to control the expression of acrEF. 4 Furthermore, it was demonstrated that acrAB is positively regulated by SdiA, a protein that regulates cell division genes in a manner dependent upon quorum sensing. 22 In this study, we found that Hfq acts as a regulator of drug resistance in E. coli. Hfq positively regulates the production of the AcrB drug efflux protein; thus, deletion of the hfq gene resulted in the decreased production of AcrB, and the hfq mutant became more susceptible to multiple drugs compared with the wild-type strain. Hfq affects the protein level of AcrB; however, it does not change the promoter activity of the acrAB operon, indicating that Hfq controls AcrB at the posttranscriptional level. The bacterial Sm-like protein Hfq facilitates RNA-RNA interaction involved in post-transcriptional regulation of the stress response. Specifically, Hfq helps pair non-coding RNAs (ncRNAs) with complementary regions of target mRNAs. E. coli Hfq mutants show disrupted signalling in stress response pathways 23 arising from the need for Hfq to mediate base pairing between regulatory ncRNAs and their mRNA targets. Examples of these partnerships include DsrA -rpoS, 23 OxySfhlA, 24 OxyS -rpoS, 25 RprA -rpoS, 26 RyhB -sodB 27 and Spot42-galETKM. 28 We considered the possibility that overproduction of Hfq from the expression vector may enhance the drug resistance level of E. coli; however, this was not observed (data not shown). This is probably because the Hfq protein is constitutively expressed (55 000 molecules/cell) 29 and it is sufficient to maintain the intrinsic drug resistance of E. coli cells. In addition to the roles of Hfq in bacterial virulence, we found a previously uncharacterized role for Hfq in multidrug resistance based on regulating the AcrB drug efflux system. However, the results still leave open the possibility that Hfq may also influence multidrug resistance by regulation of other systems in addition to AcrAB, such as other efflux systems and/or outer membrane channels, because Hfq has been shown to affect membrane composition, particularly the outer membrane proteins. 30 Further investigation of the regulation of the multidrug efflux system in several natural environments is required to elucidate the biological significance of its regulatory networks. Such an investigation may provide further insights into the role of multidrug efflux systems in the physiology of the cell. Figure 2 . Effect of Hfq on the promoter activity of the AcrAB-TolC drug efflux system. The effect of hfq deletion on the promoter activities of the acrAB operon and the tolC gene was determined using strains NKE621, NKE736, NKE641 and NKE1282 as described in the Materials and methods section. The data correspond to mean values of three independent experiments. Error bars correspond to the standard deviations.
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